MedTrace Logo

Open Label Extension Study of NCT06221852

NCT06558201 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-04-17

No results posted yet for this study

Summary

This is a 12-week open-label extension study for participants completing study NCT06221852.

Conditions

Interventions

OTHER

Ketogenic diet

The ketogenic diet (KD) is a normo-caloric diet composed of high-fat, low carbohydrate, and adequate protein intake. The KD will consist of 3 meals a day plus snacks, targeting 75-80% fat, 13-18% protein, 7% carbohydrates.

Sponsors & Collaborators

  • Baszucki Family Foundation

    collaborator UNKNOWN

  • Mclean Hospital

    lead OTHER

Principal Investigators

  • Virginie-Anne Chouinard, MD · Mclean Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-28
Primary Completion
2027-09-30
Completion
2027-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06558201 on ClinicalTrials.gov